Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-17

Clinical Trial Update: OCT-guided LALAK in Children [NA]

View source ↗

Summary

A clinical trial evaluating OCT-guided LALAK in children with corneal opacity has been terminated. No results are reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Corneal Opacity | NA | Status: TERMINATED